CDC20 and neoplasm: As CDC20 is a key activator in the Anaphase-Promoting Complex/Cyclosome (APC/C), an E3 ubiquitin ligase [10], it remains unclear whether CDC20 influences DNA damage repair via ubiquitination mechanisms and thus affects drug resistance in tumor cells.